Peter Feinberg, Director at Immuneering Corp (IMRX), bought 50,000 shares at $2.53 ($127K) on 2025-06-18, disclosed to the SEC on 2025-06-23.
Open-market purchase of $126k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.53 | 25,000 | $63K | 50.0% |
| 2 | $2.53 | 25,000 | $63K | 50.0% |
| Total | $2.53 avg | 50,000 | $127K | 100% |
| Filing → |
| IMRX | BUY | 2025-10-01 | $53K | — | Filing → |
| IMRX | BUY | 2025-09-30 | $36K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $128K | — | Filing → |